“Novo Nordisk’s aim with this nomination is to ensure that patients receive only FDA-approved, safe, and effective ...

Novo Nordisk has nominated semaglutide for inclusion in the FDA’s Demonstrable Difficulties for Compounding list, which ...

A Memorandum of Understanding between FDA and the Association of American Feed Control Officials, a group that represents ...

Imuldosa (ustekinumab-srlf) is the fifth ustekinumab biosimilar referencing Stelara to receive regulatory approval in the US.

The sellers of these online products acknowledge that many of their drugs are for ‘research purposes only’ or ‘not for human ...

Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pf | For the second time in six months, the FDA ...

Imuldosa (ustekinumab-srlf) is the fifth ustekinumab biosimilar referencing Stelara to receive regulatory approval in the US.

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Boston Scientific (BSX – Research Report) yesterday and set a price target ...

Sarfaraz K. Niazi, PhD, provides an overview of the current biosimilar education material offered by the FDA, emphasizing ...

Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune Lua® for ...

THE FUTURE OF BESPOKE WEIGHT-LOSS PRODUCTS — The shortage of popular diabetes and weight-loss drugs known as GLP-1s — and insurers’ uneven coverage of them — is putting an unprecedented ...

The Arctic Gala joins OSF's previously approved varieties, which include Arctic Golden, Arctic Granny, and Arctic Fuji. T ...